NFL BIOSCIENCES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 EUR | -2.38% |
|
+1.65% | +70.83% |
| 05-29 | NFL Biosciences: study with CEA presented at congress | CF |
| 05-21 | NFL Biosciences receives positive feedback from the FDA | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 26.23M | - | - | - | - | - | |
| 124B | ||||||
| 109B | ||||||
| 23.84B | - | |||||
| 22.42B | - | |||||
| 17.5B |
- Stock Market
- Equities
- ALNFL Stock
- Charts NFL Biosciences
- Sector Chart